Lisa B Hightow-Weidman1, Manya Magnus2, Geetha Beauchamp3, Christopher B Hurt1, Steve Shoptaw4, Lynda Emel3, Estelle Piwowar-Manning5, Kenneth H Mayer6, LaRon E Nelson7,8, Leo Wilton9,10, Phaedrea Watkins11, Darren Whitfield12, Sheldon D Fields13, Darrell Wheeler14. 1. Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill, Seattle, Washington. 2. Department of Epidemiology and Biostatistics, Milken Institute School of Public Health at the George Washington University, District of Columbia, Seattle, Washington. 3. Statistical Center for HIV/AIDS Research & Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 4. Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles. 5. Department of Pathology, John Hopkins School of Medicine, Baltimore, Maryland. 6. Fenway Institute, Fenway Health and the Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts. 7. School of Nursing, University of Rochester, New York. 8. Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada. 9. Department of Human Development, State University of New York, Binghamton. 10. Faculty of Humanities, University of Johannesburg, Auckland Park, South Africa. 11. Syneos Health, Clinical Development, Raleigh, North Carolina. 12. School of Social Work, Department of Psychiatry, School of Medicine, University of Pittsburgh, Pennsylvania. 13. School of Health Professions, New York Institute of Technology, Old Westbury. 14. Iona College, New Rochelle, New York.
Abstract
BACKGROUND: The HIV Prevention Trials Network (HPTN) Study 073 (HPTN 073) assessed the feasibility, acceptability, and safety of preexposure prophylaxis (PrEP) for black men who have sex with men (BMSM). The purpose of this analysis was to characterize the relationship between PrEP uptake and use and incident sexually transmitted infections (STIs) among participants enrolled in HPTN 073. METHODS: A total of 226 human immunodeficiency virus (HIV)-uninfected BMSM were enrolled in 3 US cities; all participants received client-centered care coordination (C4) and were offered daily oral PrEP. Participants were followed for 12 months with STI testing (rectal and urine nucleic acid amplification test for gonorrhea and chlamydia, rapid plasma reagin for syphilis) conducted at baseline, week 26, and week 52. Logistic regression was used to examine associations between STI incidence and PrEP uptake. Generalized estimating equations were used to evaluate associations between age, PrEP acceptance, sexual behaviors, and incident STIs. RESULTS: Baseline STI prevalence was 14.2%. Men aged <25 years were more likely to have a baseline STI (25.3% vs 6.7%; odds ratio [OR], 4.39; 95% confidence interval [CI:, 1.91, 10.11). Sixty participants (26.5%) acquired ≥1 STI during follow-up; the incidence rate was 34.2 cases per 100 person-years (95% CI, 27.4, 42.9). In adjusted analyses, baseline STI diagnosis (OR, 4.23; 95% CI, 1.82, 9.87; P < .001) and additional C4 time (OR, 1.03; 95% CI, 1.00, 1.06; P = .027) were associated with having an incident STI. STI incidence was not associated with PrEP acceptance or adherence. CONCLUSIONS: While we found higher rates of STIs in younger BMSM, overall rates of STI were lower than in prior PrEP trials, with no increase over time. BMSM with STIs at PrEP initiation may require additional interventions that target STI acquisition risk. CLINICAL TRIALS REGISTRATION: NCT01808352.
BACKGROUND: The HIV Prevention Trials Network (HPTN) Study 073 (HPTN 073) assessed the feasibility, acceptability, and safety of preexposure prophylaxis (PrEP) for black men who have sex with men (BMSM). The purpose of this analysis was to characterize the relationship between PrEP uptake and use and incident sexually transmitted infections (STIs) among participants enrolled in HPTN 073. METHODS: A total of 226 human immunodeficiency virus (HIV)-uninfected BMSM were enrolled in 3 US cities; all participants received client-centered care coordination (C4) and were offered daily oral PrEP. Participants were followed for 12 months with STI testing (rectal and urine nucleic acid amplification test for gonorrhea and chlamydia, rapid plasma reagin for syphilis) conducted at baseline, week 26, and week 52. Logistic regression was used to examine associations between STI incidence and PrEP uptake. Generalized estimating equations were used to evaluate associations between age, PrEP acceptance, sexual behaviors, and incident STIs. RESULTS: Baseline STI prevalence was 14.2%. Men aged <25 years were more likely to have a baseline STI (25.3% vs 6.7%; odds ratio [OR], 4.39; 95% confidence interval [CI:, 1.91, 10.11). Sixty participants (26.5%) acquired ≥1 STI during follow-up; the incidence rate was 34.2 cases per 100 person-years (95% CI, 27.4, 42.9). In adjusted analyses, baseline STI diagnosis (OR, 4.23; 95% CI, 1.82, 9.87; P < .001) and additional C4 time (OR, 1.03; 95% CI, 1.00, 1.06; P = .027) were associated with having an incident STI. STI incidence was not associated with PrEP acceptance or adherence. CONCLUSIONS: While we found higher rates of STIs in younger BMSM, overall rates of STI were lower than in prior PrEP trials, with no increase over time. BMSM with STIs at PrEP initiation may require additional interventions that target STI acquisition risk. CLINICAL TRIALS REGISTRATION: NCT01808352.
Authors: Mark Richard Stenger; Stefan Baral; Shauna Stahlman; Dan Wohlfeiler; Jerusha E Barton; Thomas Peterman Journal: Sex Health Date: 2017-02 Impact factor: 2.706
Authors: Jeremy A Grey; Kyle T Bernstein; Patrick S Sullivan; Sarah E Kidd; Thomas L Gift; Eric W Hall; Abigail Hankin-Wei; Hillard S Weinstock; Eli S Rosenberg Journal: J Acquir Immune Defic Syndr Date: 2017-11-01 Impact factor: 3.731
Authors: Nicholas Chamberlain; Richard A Crosby; Leandro Mena; Philip A Chan; Kenneth H Mayer Journal: Sex Transm Dis Date: 2017-07 Impact factor: 2.830
Authors: Craig W Hendrix; Adriana Andrade; Namandjé N Bumpus; Angela D Kashuba; Mark A Marzinke; Ayana Moore; Peter L Anderson; Lane R Bushman; Edward J Fuchs; Ilene Wiggins; Christine Radebaugh; Heather A Prince; Rahul P Bakshi; Ruili Wang; Paul Richardson; Eugenie Shieh; Laura McKinstry; Xin Li; Deborah Donnell; Vanessa Elharrar; Kenneth H Mayer; Kristine B Patterson Journal: AIDS Res Hum Retroviruses Date: 2015-10-15 Impact factor: 2.205
Authors: Derrick D Matthews; A L Herrick; Robert W S Coulter; M Reuel Friedman; Thomas C Mills; Lisa A Eaton; Patrick A Wilson; Ron D Stall Journal: AIDS Behav Date: 2016-01
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming Journal: N Engl J Med Date: 2016-07-18 Impact factor: 91.245
Authors: Kenneth H Mayer; Kevin M Maloney; Kenneth Levine; Dana King; Chris Grasso; Douglas S Krakower; Eli S Rosenberg; Stephen L Boswell Journal: Open Forum Infect Dis Date: 2017-10-08 Impact factor: 3.835
Authors: Julia L Marcus; David V Glidden; Kenneth H Mayer; Albert Y Liu; Susan P Buchbinder; K Rivet Amico; Vanessa McMahan; Esper Georges Kallas; Orlando Montoya-Herrera; Jose Pilotto; Robert M Grant Journal: PLoS One Date: 2013-12-18 Impact factor: 3.240
Authors: Derek T Dangerfield; Irene Kuo; Manya Magnus; Geetha Beauchamp; Sheldon D Fields; LaRon Nelson; Steven Shoptaw; Leo Wilton; Darrell P Wheeler Journal: Arch Sex Behav Date: 2021-09-29
Authors: Christopher Chauncey Watson; Leo Wilton; Jonathan Paul Lucas; Lawrence Bryant; Gregory D Victorianne; Kerry Aradhya; Sheldon D Fields; Darrell P Wheeler; On Behalf Of The Hptn Black Caucus Journal: Int J Environ Res Public Health Date: 2020-02-03 Impact factor: 3.390
Authors: Patrick Sean Sullivan; Ryan J Zahn; Sarah Wiatrek; Cristian J Chandler; Sabina Hirshfield; Rob Stephenson; Jose A Bauermeister; Mary Ann Chiasson; Martin J Downing; Deborah J Gelaude; Aaron J Siegler; Keith Horvath; Erin Rogers; Ana Alas; Evelyn J Olansky; Heather Saul; Eli S Rosenberg; Gordon Mansergh Journal: JMIR Res Protoc Date: 2019-11-15
Authors: S Raquel Ramos; David T Lardier; Donte T Boyd; José I Gutierrez; Eliana Carasso; David Houng; Trace Kershaw Journal: Int J Environ Res Public Health Date: 2021-05-07 Impact factor: 3.390
Authors: Katherine B Rucinski; Lisa A Eaton; Emily R Learner; Ryan J Watson; Jessica L Maksut; Valerie A Earnshaw Journal: Sex Transm Dis Date: 2020-06 Impact factor: 3.868